Federal award (DEFINITIVE CONTRACT, fiscal year 2022)
Recipient: VIA THERAPEUTICS, LLC
Awarding agency: Department of Health and Human Services / National Institutes of Health
Funding agency: Department of Health and Human Services / National Institutes of Health
Period of performance: 2023-09-15 to 2026-09-14
Current total value of award: $1468122
Description: SBIR PHASE II AWARD TO VIA THERAPEUTICS